Teva Pharmaceutical Industries
(NYSE) TEVA
Teva Pharmaceutical Industries Financials at a Glance
Market Cap
$41.14B
Revenue (TTM)
$17.35B
Net Income (TTM)
$1.56B
EPS (TTM)
$1.35
P/E Ratio
26.25
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$35.32
Volume
188,679
Open
$34.78
Price
$35.32
Volume
188,679
Open
$34.78
Previous Close
$35.32
Daily Range
$34.53 - $35.42
52-Week Range
$14.99 - $37.35
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$35.32
Volume
188,679
Open
$34.78
Previous Close
$35.32
Daily Range
$34.53 - $35.42
52-Week Range
$14.99 - $37.35
TEVA News
TEVA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Teva Pharmaceutical Industries
Industry
Pharmaceuticals
Sector
Health CareEmployees
33,346
CEO
Richard Francis
Website
www.tevapharm.comHeadquarters
Tel Aviv, 6944020, IL
TEVA Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
19%
Net Income Margin
9%
Return on Equity
22%
Return on Capital
13%
Return on Assets
4%
Earnings Yield
3.81%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$41.14B
Shares Outstanding
1.16B
Volume
188.68K
Avg. Volume
6.75M
Financials (TTM)
Gross Profit
$8.94B
Operating Income
$2.16B
EBITDA
$3.14B
Operating Cash Flow
$1.65B
Capital Expenditure
-$501.00M
Free Cash Flow
$1.15B
Cash & ST Invst.
$3.56B
Total Debt
$17.38B
Teva Pharmaceutical Industries Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.98B
+2.3%
Gross Profit
$1.97B
+5.1%
Gross Margin
49.54%
N/A
Market Cap
$41.14B
N/A
Market Cap/Employee
$1.11M
N/A
Employees
37,000
N/A
Net Income
$369.00M
+72.4%
EBITDA
$877.00M
+14.9%
Quarterly Fundamentals
Net Cash
-$13.17B
+13.6%
Accounts Receivable
$3.39B
+0.3%
Inventory
$3.18B
-2.2%
Long Term Debt
$14.30B
-13.5%
Short Term Debt
$2.61B
+520.4%
Return on Assets
3.90%
N/A
Return on Invested Capital
12.62%
N/A
Free Cash Flow
-$208.00M
+10.3%
Operating Cash Flow
-$40.00M
+61.9%